Company · CIK 0001850270 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
PROKIDNEY CORP. · PROK
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 18, 2026 SForm 4 → | Aug 20, 5:00 pm EDT | Brian JG PereiraDirector | 757,164 | $1.41 | $1,067,773 | 0 | −100% | |
| Aug 4, 2026 CForm 4 → | Aug 6, 8:09 am EDT | Brian JG PereiraDirector | 757,164 | — | — | 675,235 | — | |
| Jun 12, 2026 CForm 4 → | Jun 15, 5:32 pm EDT | Todd C GirolamoChief Legal Officer | 163,857 | — | — | 327,713 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 4, 2026 CForm 4 → | Aug 6, 8:09 am EDT | Brian JG PereiraDirector | 1,514,328 | — | — | 0 | — | |
| Jul 1, 2026 AForm 4 → | Jul 6, 4:02 pm EDT | Kenneth Thomas LockeChief Technical Officer | 750,000 | — | — | 750,000 | — | |
| Jun 12, 2026 CForm 4 → | Jun 15, 5:32 pm EDT | Todd C GirolamoChief Legal Officer | 327,714 | — | — | 0 | — |